spacer
spacer
Go to PDB code: 
protein ligands metals Protein-protein interface(s) links
Gene regulation PDB id
1gzh
Jmol
Contents
Protein chains
187 a.a. *
225 a.a. *
196 a.a. *
213 a.a. *
Ligands
SO4 ×2
Metals
_ZN ×2
Waters ×110
* Residue conservation analysis
PDB id:
1gzh
Name: Gene regulation
Title: Crystal structure of the brct domains of human 53bp1 bound to the p53 tumor supressor
Structure: Cellular tumor antigen p53. Chain: a. Fragment: DNA binding region, residues 95-292. Synonym: tumor suppressor p53, phosphoprotein p53, antigen ny-co-13. Engineered: yes. Cellular tumor antigen p53. Chain: c. Fragment: DNA binding region, residues 95-292.
Source: Homo sapiens. Human. Organism_taxid: 9606. Expressed in: escherichia coli. Expression_system_taxid: 562.
Biol. unit: Dimer (from PDB file)
Resolution:
2.6Å     R-factor:   0.238     R-free:   0.288
Authors: D.J.Derbyshire,A.J.Doherty
Key ref:
D.J.Derbyshire et al. (2002). Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor. EMBO J, 21, 3863-3872. PubMed id: 12110597 DOI: 10.1093/emboj/cdf383
Date:
22-May-02     Release date:   27-Jun-02    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P04637  (P53_HUMAN) -  Cellular tumor antigen p53
Seq:
Struc:
393 a.a.
187 a.a.
Protein chain
Pfam   ArchSchema ?
Q12888  (TP53B_HUMAN) -  Tumor suppressor p53-binding protein 1
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1972 a.a.
225 a.a.
Protein chain
Pfam   ArchSchema ?
P04637  (P53_HUMAN) -  Cellular tumor antigen p53
Seq:
Struc:
393 a.a.
196 a.a.
Protein chain
Pfam   ArchSchema ?
Q12888  (TP53B_HUMAN) -  Tumor suppressor p53-binding protein 1
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1972 a.a.
213 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     intracellular   2 terms 
  Biological process     apoptosis   2 terms 
  Biochemical function     transcription regulatory region DNA binding     3 terms  

 

 
DOI no: 10.1093/emboj/cdf383 EMBO J 21:3863-3872 (2002)
PubMed id: 12110597  
 
 
Crystal structure of human 53BP1 BRCT domains bound to p53 tumour suppressor.
D.J.Derbyshire, B.P.Basu, L.C.Serpell, W.S.Joo, T.Date, K.Iwabuchi, A.J.Doherty.
 
  ABSTRACT  
 
The BRCT (BRCA1 C-terminus) is an evolutionary conserved protein-protein interacting module found as single, tandem or multiple repeats in a diverse range of proteins known to play roles in the DNA-damage response. The BRCT domains of 53BP1 bind to the tumour suppressor p53. To investigate the nature of this interaction, we have determined the crystal structure of the 53BP1 BRCT tandem repeat in complex with the DNA-binding domain of p53. The structure of the 53BP1-p53 complex shows that the BRCT tandem repeats pack together through a conserved interface that also involves the inter-domain linker. A comparison of the structure of the BRCT region of 53BP1 with the BRCA1 BRCT tandem repeat reveals that the interdomain interface and linker regions are remarkably well conserved. 53BP1 binds to p53 through contacts with the N-terminal BRCT repeat and the inter-BRCT linker. The p53 residues involved in this binding are mutated in cancer and are also important for DNA binding. We propose that BRCT domains bind to cellular target proteins through a conserved structural element termed the 'BRCT recognition motif'.
 
  Selected figure(s)  
 
Figure 1.
Figure 1 Crystal structure of the 53BP1−p53 complex. Structure of the asymmetric unit containing four molecules, two heterodimers (I and II) of p53 DNA-binding domain (brown) in complex with the BRCT tandem repeat of 53BP1 (blue and pink). The heterodimers pack together mainly through contacts made between the N-terminal region of 53BP1. There are no contacts made between the adjacent p53 molecules. The single zinc atom bound to p53 is shown in yellow and the 53BP1 inter-domain linker is shown in green. 'Missing' residues in the structure are denoted by an asterisk.
Figure 5.
Figure 5 A conserved protein binding motif in BRCT domains. (A) Superimposition of the conserved p53-binding motif. This shows a superimposition of the p53-binding interface of 53BP1 (green; residues 1829−1849) with the comparable regions of the BRCT domains of BRCA1 (blue; 1716−1738) and XRCC1 (yellow; 72−94). The C[ ]backbone of these regions overlap with an r.m.s.d. of <1 Å. The position of this motif in relation to p53 binding is also shown (p53 core domain is shown in brown). (B) The highly conserved Trp residue on 3 is positioned in an identical position in all three structures (for clarity only a single Trp is shown) and stacks against the conserved Tyr residue (the superimposed Tyr shown). Two conserved 53BP1−p53 interactions are shown, Arg 248−Leu 1847 and Met 243−Tyr1846.
 
  The above figures are reprinted from an Open Access publication published by Macmillan Publishers Ltd: EMBO J (2002, 21, 3863-3872) copyright 2002.  
  Figures were selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
21361779 S.T.Al Rashid, S.M.Harding, C.Law, C.Coackley, and R.G.Bristow (2011).
Protein-protein interactions occur between p53 phosphoforms and ATM and 53BP1 at sites of exogenous DNA damage.
  Radiat Res, 175, 588-598.  
  20516128 A.C.Joerger, and A.R.Fersht (2010).
The tumor suppressor p53: from structures to drug discovery.
  Cold Spring Harb Perspect Biol, 2, a000919.  
20081839 A.T.Noon, A.Shibata, N.Rief, M.Löbrich, G.S.Stewart, P.A.Jeggo, and A.A.Goodarzi (2010).
53BP1-dependent robust localized KAP-1 phosphorylation is essential for heterochromatic DNA double-strand break repair.
  Nat Cell Biol, 12, 177-184.  
20231313 E.Vernersson-Lindahl, and A.A.Mills (2010).
{Delta}Np73{beta} puts the brakes on DNA repair.
  Genes Dev, 24, 517-520.  
20010693 J.H.Lee, A.A.Goodarzi, P.A.Jeggo, and T.T.Paull (2010).
53BP1 promotes ATM activity through direct interactions with the MRN complex.
  EMBO J, 29, 574-585.  
20081198 M.Kobayashi, E.Ab, A.M.Bonvin, and G.Siegal (2010).
Structure of the DNA-bound BRCA1 C-terminal region from human replication factor C p140 and model of the protein-DNA complex.
  J Biol Chem, 285, 10087-10097.
PDB code: 2k7f
20194434 M.T.Wilhelm, A.Rufini, M.K.Wetzel, K.Tsuchihara, S.Inoue, R.Tomasini, A.Itie-Youten, A.Wakeham, M.Arsenian-Henriksson, G.Melino, D.R.Kaplan, F.D.Miller, and T.W.Mak (2010).
Isoform-specific p73 knockout mice reveal a novel role for delta Np73 in the DNA damage response pathway.
  Genes Dev, 24, 549-560.  
19925808 M.W.Richards, J.W.Leung, S.M.Roe, K.Li, J.Chen, and R.Bayliss (2010).
A pocket on the surface of the N-terminal BRCT domain of Mcph1 is required to prevent abnormal chromosome condensation.
  J Mol Biol, 395, 908-915.
PDB code: 2wt8
  20862368 T.Ochi, B.L.Sibanda, Q.Wu, D.Y.Chirgadze, V.M.Bolanos-Garcia, and T.L.Blundell (2010).
Structural biology of DNA repair: spatial organisation of the multicomponent complexes of nonhomologous end joining.
  J Nucleic Acids, 2010, 0.  
19286366 A.L.Okorokov, and E.V.Orlova (2009).
Structural biology of the p53 tumour suppressor.
  Curr Opin Struct Biol, 19, 197-202.  
19229884 H.Hosako, G.S.Martin, M.Barrier, Y.A.Chen, I.V.Ivanov, and P.E.Mirkes (2009).
Gene and microRNA expression in p53-deficient day 8.5 mouse embryos.
  Birth Defects Res A Clin Mol Teratol, 85, 546-555.  
19452558 I.Drikos, G.Nounesis, and C.E.Vorgias (2009).
Characterization of cancer-linked BRCA1-BRCT missense variants and their interaction with phosphoprotein targets.
  Proteins, 77, 464-476.  
19804756 J.Lloyd, J.R.Chapman, J.A.Clapperton, L.F.Haire, E.Hartsuiker, J.Li, A.M.Carr, S.P.Jackson, and S.J.Smerdon (2009).
A supramodular FHA/BRCT-repeat architecture mediates Nbs1 adaptor function in response to DNA damage.
  Cell, 139, 100-111.  
19289498 K.Liu, N.Bellam, H.Y.Lin, B.Wang, C.R.Stockard, W.E.Grizzle, and W.C.Lin (2009).
Regulation of p53 by TopBP1: a potential mechanism for p53 inactivation in cancer.
  Mol Cell Biol, 29, 2673-2693.  
19234526 M.A.Adams-Cioaba, and J.Min (2009).
Structure and function of histone methylation binding proteins.
  Biochem Cell Biol, 87, 93.  
19656881 S.G.Bailey, E.Verrall, C.Schelcher, A.Rhie, A.J.Doherty, and A.J.Sinclair (2009).
Functional interaction between Epstein-Barr virus replication protein Zta and host DNA damage response protein 53BP1.
  J Virol, 83, 11116-11122.  
18986980 Y.Eliezer, L.Argaman, A.Rhie, A.J.Doherty, and M.Goldberg (2009).
The Direct Interaction between 53BP1 and MDC1 Is Required for the Recruitment of 53BP1 to Sites of Damage.
  J Biol Chem, 284, 426-435.  
  19558684 Y.Tan, and R.Luo (2009).
Structural and functional implications of p53 missense cancer mutations.
  PMC Biophys, 2, 5.  
18410249 A.C.Joerger, and A.R.Fersht (2008).
Structural biology of the tumor suppressor p53.
  Annu Rev Biochem, 77, 557-582.  
18579587 A.Kumar, W.S.Joo, G.Meinke, S.Moine, E.N.Naumova, and P.A.Bullock (2008).
Evidence for a structural relationship between BRCT domains and the helicase domains of the replication initiators encoded by the Polyomaviridae and Papillomaviridae families of DNA tumor viruses.
  J Virol, 82, 8849-8862.  
18315848 A.Madhumalar, D.J.Smith, and C.Verma (2008).
Stability of the core domain of p53: insights from computer simulations.
  BMC Bioinformatics, 9, S17.  
18647606 E.Eryilmaz, J.Benach, M.Su, J.Seetharaman, K.Dutta, H.Wei, P.Gottlieb, J.F.Hunt, and R.Ghose (2008).
Structure and dynamics of the P7 protein from the bacteriophage phi 12.
  J Mol Biol, 382, 402-422.
PDB code: 2q82
18285658 J.Kobayashi, K.Iwabuchi, K.Miyagawa, E.Sonoda, K.Suzuki, M.Takata, and H.Tauchi (2008).
Current topics in DNA double-strand break repair.
  J Radiat Res (Tokyo), 49, 93.  
18676809 M.L.Kilkenny, A.S.Doré, S.M.Roe, K.Nestoras, J.C.Ho, F.Z.Watts, and L.H.Pearl (2008).
Structural and functional analysis of the Crb2-BRCT2 domain reveals distinct roles in checkpoint signaling and DNA damage repair.
  Genes Dev, 22, 2034-2047.
PDB codes: 2vxb 2vxc
18452305 Y.Shen, and L.Tong (2008).
Structural evidence for direct interactions between the BRCT domains of human BRCA1 and a phospho-peptide from human ACC1.
  Biochemistry, 47, 5767-5773.
PDB code: 3coj
17401432 A.C.Joerger, and A.R.Fersht (2007).
Structure-function-rescue: the diverse nature of common p53 cancer mutants.
  Oncogene, 26, 2226-2242.  
  19690636 A.Horiuchi, C.Wang, N.Kikuchi, R.Osada, T.Nikaido, and I.Konishi (2007).
BRCA1 Expression is an Important Biomarker for Chemosensitivity: Suppression of BRCA1 Increases the Apoptosis via Up-regulation of p53 and p21 During Cisplatin Treatment in Ovarian Cancer Cells.
  Biomark Insights, 1, 49-59.  
  17505536 A.Hoshino, C.J.Yee, M.Campbell, R.L.Woltjer, R.L.Townsend, R.van der Meer, Y.Shyr, J.T.Holt, H.L.Moses, and R.A.Jensen (2007).
Effects of BRCA1 transgene expression on murine mammary gland development and mutagen-induced mammary neoplasia.
  Int J Biol Sci, 3, 281-291.  
17452983 A.R.Clarke, N.Jones, F.Pryde, Y.Adachi, and O.J.Sansom (2007).
53BP1 deficiency in intestinal enterocytes does not alter the immediate response to ionizing radiation, but leads to increased nuclear area consistent with polyploidy.
  Oncogene, 26, 6349-6355.  
17063491 C.A.Gough, T.Gojobori, and T.Imanishi (2007).
Cancer-related mutations in BRCA1-BRCT cause long-range structural changes in protein-protein binding sites: a molecular dynamics study.
  Proteins, 66, 69-86.  
17915942 E.F.DeRose, M.W.Clarkson, S.A.Gilmore, C.J.Galban, A.Tripathy, J.M.Havener, G.A.Mueller, D.A.Ramsden, R.E.London, and A.L.Lee (2007).
Solution structure of polymerase mu's BRCT Domain reveals an element essential for its role in nonhomologous end joining.
  Biochemistry, 46, 12100-12110.
PDB code: 2htf
17308087 M.A.Carvalho, S.M.Marsillac, R.Karchin, S.Manoukian, S.Grist, R.F.Swaby, T.P.Urmenyi, E.Rondinelli, R.Silva, L.Gayol, L.Baumbach, R.Sutphen, J.L.Pickard-Brzosowicz, K.L.Nathanson, A.Sali, D.Goldgar, F.J.Couch, P.Radice, and A.N.Monteiro (2007).
Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis.
  Cancer Res, 67, 1494-1501.  
  18231732 M.Wang, S.Liu, and P.Liu (2007).
Gene expression profile of multiple myeloma cell line treated by arsenic trioxide.
  J Huazhong Univ Sci Technolog Med Sci, 27, 646-649.  
17015838 A.C.Joerger, H.C.Ang, and A.R.Fersht (2006).
Structural basis for understanding oncogenic p53 mutations and designing rescue drugs.
  Proc Natl Acad Sci U S A, 103, 15056-15061.
PDB codes: 2j1w 2j1x 2j1y 2j1z 2j20 2j21
17053786 A.L.Okorokov, M.B.Sherman, C.Plisson, V.Grinkevich, K.Sigmundsson, G.Selivanova, J.Milner, and E.V.Orlova (2006).
The structure of p53 tumour suppressor protein reveals the basis for its functional plasticity.
  EMBO J, 25, 5191-5200.  
17094803 D.C.Zappulla, A.S.Maharaj, J.J.Connelly, R.A.Jockusch, and R.Sternglanz (2006).
Rtt107/Esc4 binds silent chromatin and DNA repair proteins using different BRCT motifs.
  BMC Mol Biol, 7, 40.  
17043355 I.Ward, J.E.Kim, K.Minn, C.C.Chini, G.Mer, and J.Chen (2006).
The tandem BRCT domain of 53BP1 is not required for its repair function.
  J Biol Chem, 281, 38472-38477.  
17161371 J.Liu, Y.Pan, B.Ma, and R.Nussinov (2006).
"Similarity trap" in protein-protein interactions could be carcinogenic: simulations of p53 core domain complexed with 53BP1 and BRCA1 BRCT domains.
  Structure, 14, 1811-1821.  
16793544 M.Kitayner, H.Rozenberg, N.Kessler, D.Rabinovich, L.Shaulov, T.E.Haran, and Z.Shakked (2006).
Structural basis of DNA recognition by p53 tetramers.
  Mol Cell, 22, 741-753.
PDB codes: 2ac0 2ady 2ahi 2ata
16361700 M.Kobayashi, F.Figaroa, N.Meeuwenoord, L.E.Jansen, and G.Siegal (2006).
Characterization of the DNA binding and structural properties of the BRCT region of human replication factor C p140 subunit.
  J Biol Chem, 281, 4308-4317.  
16945145 M.M.Adams, and P.B.Carpenter (2006).
Tying the loose ends together in DNA double strand break repair with 53BP1.
  Cell Div, 1, 19.  
16397295 N.Lévy, A.Martz, A.Bresson, C.Spenlehauer, G.de Murcia, and J.Ménissier-de Murcia (2006).
XRCC1 is phosphorylated by DNA-dependent protein kinase in response to DNA damage.
  Nucleic Acids Res, 34, 32-41.  
16951253 W.Lilyestrom, M.G.Klein, R.Zhang, A.Joachimiak, and X.S.Chen (2006).
Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressor.
  Genes Dev, 20, 2373-2382.
PDB code: 2h1l
15703170 A.C.Joerger, H.C.Ang, D.B.Veprintsev, C.M.Blair, and A.R.Fersht (2005).
Structures of p53 cancer mutants and mechanism of rescue by second-site suppressor mutations.
  J Biol Chem, 280, 16030-16037.
PDB codes: 2bim 2bin 2bio 2bip 2biq
15611070 A.Friedler, D.B.Veprintsev, T.Rutherford, K.I.von Glos, and A.R.Fersht (2005).
Binding of Rad51 and other peptide sequences to a promiscuous, highly electrostatic binding site in p53.
  J Biol Chem, 280, 8051-8059.  
16218947 A.K.Dunker, M.S.Cortese, P.Romero, L.M.Iakoucheva, and V.N.Uversky (2005).
Flexible nets. The roles of intrinsic disorder in protein interaction networks.
  FEBS J, 272, 5129-5148.  
16204849 B.Ma, Y.Pan, K.Gunasekaran, O.Keskin, R.B.Venkataraghavan, A.J.Levine, and R.Nussinov (2005).
The contribution of the Trp/Met/Phe residues to physical interactions of p53 with cellular proteins.
  Phys Biol, 2, S56-S66.  
15593246 F.J.Stevens, C.Kuemmel, G.Babnigg, and F.R.Collart (2005).
Efficient recognition of protein fold at low sequence identity by conservative application of Psi-BLAST: application.
  J Mol Recognit, 18, 150-157.  
16260621 I.M.Ward, S.Difilippantonio, K.Minn, M.D.Mueller, J.R.Molina, X.Yu, C.S.Frisk, T.Ried, A.Nussenzweig, and J.Chen (2005).
53BP1 cooperates with p53 and functions as a haploinsufficient tumor suppressor in mice.
  Mol Cell Biol, 25, 10079-10086.  
16285867 J.M.Daley, P.L.Palmbos, D.Wu, and T.E.Wilson (2005).
Nonhomologous end joining in yeast.
  Annu Rev Genet, 39, 431-451.  
15611139 K.W.Lo, H.M.Kan, L.N.Chan, W.G.Xu, K.P.Wang, Z.Wu, M.Sheng, and M.Zhang (2005).
The 8-kDa dynein light chain binds to p53-binding protein 1 and mediates DNA damage-induced p53 nuclear accumulation.
  J Biol Chem, 280, 8172-8179.  
16049003 M.S.Lee, R.A.Edwards, G.L.Thede, and J.N.Glover (2005).
Structure of the BRCT repeat domain of MDC1 and its specificity for the free COOH-terminal end of the gamma-H2AX histone tail.
  J Biol Chem, 280, 32053-32056.
PDB code: 2ado
16377563 M.Stucki, J.A.Clapperton, D.Mohammad, M.B.Yaffe, S.J.Smerdon, and S.P.Jackson (2005).
MDC1 directly binds phosphorylated histone H2AX to regulate cellular responses to DNA double-strand breaks.
  Cell, 123, 1213-1226.
PDB code: 2azm
15661530 X.Lu (2005).
p53: a heavily dictated dictator of life and death.
  Curr Opin Genet Dev, 15, 27-33.  
14978302 C.M.Ekblad, A.Friedler, D.Veprintsev, R.L.Weinberg, and L.S.Itzhaki (2004).
Comparison of BRCT domains of BRCA1 and 53BP1: a biophysical analysis.
  Protein Sci, 13, 617-625.  
15341721 G.Charier, J.Couprie, B.Alpha-Bazin, V.Meyer, E.Quéméneur, R.Guérois, I.Callebaut, B.Gilquin, and S.Zinn-Justin (2004).
The Tudor tandem of 53BP1: a new structural motif involved in DNA and RG-rich peptide binding.
  Structure, 12, 1551-1562.
PDB code: 1ssf
15133502 J.A.Clapperton, I.A.Manke, D.M.Lowery, T.Ho, L.F.Haire, M.B.Yaffe, and S.J.Smerdon (2004).
Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.
  Nat Struct Mol Biol, 11, 512-518.
PDB code: 1t15
15501676 J.N.Glover, R.S.Williams, and M.S.Lee (2004).
Interactions between BRCT repeats and phosphoproteins: tangled up in two.
  Trends Biochem Sci, 29, 579-585.  
15229228 L.L.Du, B.A.Moser, and P.Russell (2004).
Homo-oligomerization is the essential function of the tandem BRCT domains in the checkpoint protein Crb2.
  J Biol Chem, 279, 38409-38414.  
15456759 P.A.Jowsey, A.J.Doherty, and J.Rouse (2004).
Human PTIP facilitates ATM-mediated activation of p53 and promotes cellular resistance to ionizing radiation.
  J Biol Chem, 279, 55562-55569.  
15133503 R.S.Williams, M.S.Lee, D.D.Hau, and J.N.Glover (2004).
Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1.
  Nat Struct Mol Biol, 11, 519-525.
PDB codes: 1t2u 1t2v
12640136 I.M.Ward, K.Minn, J.van Deursen, and J.Chen (2003).
p53 Binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice.
  Mol Cell Biol, 23, 2556-2563.  
12824158 K.Iwabuchi, B.P.Basu, B.Kysela, T.Kurihara, M.Shibata, D.Guan, Y.Cao, T.Hamada, K.Imamura, P.A.Jeggo, T.Date, and A.J.Doherty (2003).
Potential role for 53BP1 in DNA end-joining repair through direct interaction with DNA.
  J Biol Chem, 278, 36487-36495.  
12591941 K.Kamada, R.G.Roeder, and S.K.Burley (2003).
Molecular mechanism of recruitment of TFIIF- associating RNA polymerase C-terminal domain phosphatase (FCP1) by transcription factor IIF.
  Proc Natl Acad Sci U S A, 100, 2296-2299.
PDB code: 1j2x
12679336 K.M.Cerosaletti, and P.Concannon (2003).
Nibrin forkhead-associated domain and breast cancer C-terminal domain are both required for nuclear focus formation and phosphorylation.
  J Biol Chem, 278, 21944-21951.  
14576410 K.W.Caldecott (2003).
Cell signaling. The BRCT domain: signaling with friends?
  Science, 302, 579-580.  
12475977 Y.L.Shang, A.J.Bodero, and P.L.Chen (2003).
NFBD1, a novel nuclear protein with signature motifs of FHA and BRCT, and an internal 41-amino acid repeat sequence, is an early participant in DNA damage response.
  J Biol Chem, 278, 6323-6329.  
12432406 E.V.Koonin, Y.I.Wolf, and G.P.Karev (2002).
The structure of the protein universe and genome evolution.
  Nature, 420, 218-223.  
12461529 R.T.Abraham (2002).
Checkpoint signalling: focusing on 53BP1.
  Nat Cell Biol, 4, E277-E279.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.